The Rel/NF-B family of transcription factors regulates the expression of genes involved in immune and stress responses, differentiation, proliferation, and apoptosis (10, 17, 29) . Members of this family, which include c-Rel, v-Rel, RelA, RelB, NF-B1 (p50/p105), and NF-B2 (p52/p100), contain a highly conserved 300-amino-acid region in their N termini termed the Rel homology domain (RHD). The RHD contains sequences that allow these proteins to form homo-and heterodimers, bind DNA, and associate with inhibitory proteins (IBs) such as IB␣. In most cell types, Rel/NF-B dimers are normally sequestered as inactive complexes in the cytoplasm of cells by association with IBs. Appropriate extracellular stimuli induce the phosphorylation, ubiquitination, and subsequent degradation of IBs, allowing for the nuclear translocation of active Rel/NF-B dimers (18) . In the nuclei of cells, Rel/NF-B dimers exert their regulatory effects by binding to sequences (B sites) present in promoters and enhancers of target genes.
The v-rel oncogene is the only acutely transforming member of the Rel/NF-B family. Viruses expressing v-Rel induce a rapid and invariably fatal lymphoma in young birds 7 to 10 days after infection (3) . v-rel was derived by a nonhomologous recombination event between turkey c-rel and reticuloendotheliosis-associated virus strain A (REV-A). While c-Rel is weakly transforming, v-Rel has acquired a number of structural changes that account for its high transformation potential (9) .
The transduction of c-rel into REV-A resulted in the deletion of sequences encoding 118 C-terminal amino acids of c-Rel, removing its most potent transactivation domain. This region of c-Rel also contains a cytoplasmic retention element, the loss of which contributes to the increased nuclear access of v-Rel (5) . In addition, v-Rel has acquired a number of amino acid substitutions and deletions that alter its DNA-binding specificity and make it refractory to IB␣ regulation (5, 24, 27) . The increased nuclear access and altered DNA binding and transactivation properties of v-Rel contribute to its transforming potential by allowing the inappropriate activation or suppression of genes normally regulated by Rel/NF-B family members (7, 9, 28) .
The ability of a cell to escape apoptosis is a critical step in the transformation process, and several studies have demonstrated that the expression of v-Rel inhibits cell death induced by a variety of apoptotic stimuli (26, 30, 31, 35, 36) . Apoptosis results from the activation of a conserved, constitutively expressed group of cysteine proteases called caspases (1, 11) . The activity of caspases is regulated, in part, by their interaction with members of the inhibitor-of-apoptosis (IAP) family. Our laboratory identified and cloned ch-IAP1, an avian IAP family member, and demonstrated that its expression was highly elevated in v-Rel-transformed cells but only modestly elevated in cells transformed by the overexpression of c-Rel (32) . Studies using lymphoid cells transformed by a temperature-sensitive v-Rel mutant revealed that induction of ch-IAP1 mRNA and protein correlated with the expression of v-Rel, suggesting that ch-IAP1 was directly regulated by v-Rel (32) . Furthermore, ectopic expression of ch-IAP1 prevented these cells from un-dergoing apoptosis at the nonpermissive temperature, indicating that ch-IAP1 mediates, at least in part, the ability of v-Rel to inhibit apoptosis (32) .
The studies reported here characterize the regulation of ch-IAP1 expression by v-Rel and c-Rel. A region of chicken genomic DNA encompassing the ch-IAP1 promoter was isolated and sequenced. Four Rel/NF-B binding sites were identified within 386 bp of the transcription start site. The contribution of each site to the differential regulation of the ch-IAP1 promoter by v-Rel and c-Rel was evaluated. Although c-Rel was a more potent activator of ch-IAP1 transcription in reporter assays, kinetic analyses revealed that v-Rel, but not c-Rel, induced sustained elevated levels of ch-IAP1. Our results suggest that the high levels of ch-IAP1 in v-Rel-transformed cells result from the ability of v-Rel to escape the regulatory effects of ⌱B␣.
MATERIALS AND METHODS

Cells and viruses.
Chicken embryo fibroblast (CEF) cultures were prepared from embryonated SPAFAS or SC eggs (Charles River Laboratories, Preston, Conn.) as previously described (22) . The avian leukosis virus-transformed chicken B-cell line DT40, the v-Rel-transformed B-cell line 7.4.1 (originally named RECC-UT1W41), and the Marek's disease virus-transformed T-cell line MSB-1 have been previously described (2, 15, 34) . All cell cultures were maintained in Dulbecco's modified Eagle's medium supplemented with 2% chicken serum (Life Technologies, Gaithersburg, Md.), 3% newborn calf serum, 3% fetal calf serum (HyClone Laboratories, Logan, Utah), penicillin (100 U/ml), and streptomycin (50 g/ml) and incubated in a 37°C incubator containing 8% CO 2 .
REV-A, chicken syncytial virus (CSV), and REV-based retroviruses expressing v-Rel (REV-TW) or c-Rel (REV-C) have been described previously (15) . Retroviral stocks were prepared by transfecting CEF cultures with plasmids encoding these retroviruses and harvesting supernatant fluids after 5 to 7 days. Titers of REV-TW and REV-C viral stocks were determined by dot blot analysis, using REV-TW previously quantitated by an immunohistochemical assay as a standard (15, 25) .
Nuclear run-on analysis. Nuclear run-on reactions were performed as previously described (19) . Briefly, genomic DNA (2 g) isolated from each cell line and linearized plasmids (1 g) encoding full-length c-jun or ch-IAP1 or empty pBluescript SK(Ϫ) (Stratagene, La Jolla, Calif.) were denatured, neutralized, and slot blotted onto Hybond N ϩ (Amersham Pharmacia Biotech, Piscataway, N.J.). Nuclei were isolated from 10 8 cells by using a modified NP-40 lysis protocol and were employed for the synthesis of run-on RNA transcripts in the presence of [ 32 P]UTP (New England Nuclear, Boston, Mass.) (6) . Equivalent amounts of radioactivity (2 ϫ 10 7 cpm) from each nuclear run-on reaction were hybridized with the prepared membranes at 40°C for 72 h. The membranes were washed extensively, and bound radioactivity was quantitated by phosphorimager analysis.
RNA half-life and Northern blot analysis. Northern blot analysis was performed as previously described (28) . Probes for ch-IAP1, ␤-actin, and glyceraldehyde-3-phosphate dehydrogenase (GAPDH) were prepared from full-length cDNA templates and labeled with [ 32 P]dCTP (New England Nuclear) by using the Prime-a-Gene random-priming labeling kit (Promega, Madison, Wis.). For mRNA half-life analysis, DT40 cells infected with REV-A or REV-TW were treated with actinomycin D (2.5 g/ml), and total RNA was isolated at various times after the start of treatment with the RNAwiz reagent according to the manufacturer's directions (Ambion, Austin, Tex.). RNA (10 g) was fractionated on a 1% agarose gel containing formaldehyde, transferred by capillary action to nylon membranes (Hybond N ϩ ; Amersham), and hybridized with a ch-IAP1-specific probe by using the ULTRAhyb reagent according to the manufacturer's directions (Ambion) (22) . ch-IAP1 RNA levels were quantitated by phosphorimager analysis. The blot was stripped and reprobed with an actin-specific probe to normalize the signals obtained. Due to the low level of expression of ch-IAP1 in DT40 cells infected with REV-A, longer exposure times were required for these blots.
Primer extension analysis. Primer extension was performed by using the Primer Extension System-AMV Reverse Transcriptase kit according to the manufacturer's directions (Promega). A primer (5Ј-CGTTTGAGGTGCCTACGC-3Ј) complementary to nucleotides between 110 and 93 of the ch-IAP1 cDNA was end labeled with [ 32 P]ATP using T4 polynucleotide kinase. This primer was hybridized with poly(A) ϩ RNA (1 g) isolated from 7.4.1 or MSB-1 cells by using the Oligotex mRNA mini kit (Qiagen, Valencia, Calif.). Extension products were resolved by electrophoresis on a 7 M urea-acrylamide gel in parallel to a DNA sequencing reaction. Conventionally, the location of the transcription start site within the genomic clone is determined by comparing the size of a primer extension product to that of a sequencing reaction performed using the genomic clone as a template and the primer extension primer as the sequencing primer. However, this was not possible, since an intron is present between the annealing site for the primer extension primer and the sequence corresponding to the 5Ј end of the ch-IAP1 cDNA. Therefore, a sequencing reaction was performed with pGEM-3Zf(ϩ) and the M13 forward primer using the fmol DNA cycle sequencing system (Promega), which provided standards of known lengths.
Isolation of a ch-IAP1 genomic clone. A chicken genomic library in bacteriophage lambda (ATCC 37501; American Type Culture Collection, Manassas, Va.) was screened with a 650-bp ApaI fragment from the 5Ј end of the ch-IAP1 cDNA as a probe. Two independently isolated clones containing sequences corresponding to the 5Ј end of the ch-IAP1 cDNA were isolated. Both clones appeared to contain fragments of identical size and composition, as determined by restriction mapping and Southern blot hybridization with the same probe. A fragment of approximately 10 kb flanked by EcoRI sites was subcloned into pBluescript SK(Ϫ) (E10), and both strands were sequenced by automated DNA sequencing at the University of Texas DNA Core Facility.
Reporter plasmids and site-directed mutagenesis. The 1.2-kb PstI fragment of E10 was subcloned into the PstI site of pBluescript SK(Ϫ) to generate P1.2. This fragment was excised by digestion with XhoI and SacI and ligated into the corresponding sites of the pGL3-Basic luciferase reporter vector (Promega) to prepare IAP1-luc. IAP1-luc was digested with BstXI and Bsu36I, blunt ended with T4 DNA polymerase, and self-ligated to make IAP2-luc. An XhoI-SacI fragment of IAP1-luc was digested with PspGI, blunt ended by treatment with Klenow, and then digested with HindIII. The resulting fragment was subcloned into SmaI and HindIII sites of the pGL3-Basic vector to generate IAP3-Luc. The 1.2-kb PstI fragment of E10 was digested with BsrBI, and a 0.55-kb BsrBI/PstI fragment was purified, blunt ended with T4 DNA polymerase, and ligated into the SmaI site of pGL3-Basic to generate IAP4-luc. A 0.35-kb NcoI-PstI fragment of P1.2 was blunt ended with T4 DNA polymerase and subcloned into the SmaI site of pGL3-Basic to make IAP5-luc. All constructs were sequenced to verify proper orientation of the subcloned fragments.
Site-directed mutagenesis was performed using either the Altered Sites sitedirected mutagenesis kit (Clontech, Palo Alto, Calif.) or the Gene Editor sitedirected mutagenesis kit (Promega) in accordance with the manufacturers' instructions. To mutate each of the four B sites in IAP2-luc, primers B1m (5Ј-GGCGCGGGGTTCtgCACGCAGAACGT-3Ј), B2m (5Ј-CGGGACGGC GGGTGCTTTgCTGGCGGCGCGG-3Ј), B1/2m (5Ј-CGGGACGGCGGGT GCTTTgCTGGCGGCGCGGGGGTTCtgCACGCAGAACGT-3Ј), B3m (5Ј-CGCGTCGCTGcaGCTTTCCGGC-3Ј), and B4m (5Ј-CGCTCCCCTCGcAG TTTCgCGGGCCGGGG-3Ј) were employed. The underlined sequences indicate the location of the B site, and lowercase letters indicate mutated nucleotide positions.
Transient-transfection and luciferase assays. For transient-transfection assays, the expression vector pRc/RSV (Invitrogen, Carlsbad, Calif.) and pRc/RSV encoding v-Rel, c-Rel, c-Rel⌬T, or ttc-Rel were employed. The construction of c-Rel⌬T and ttc-Rel has been described previously (14) . CEF cultures were plated in 60-mm tissue culture dishes (7.5 ϫ 10 5 cells/plate) 24 h before transfection. Cells were transfected using a calcium phosphate precipitation protocol (20) . A total of 10 g of DNA was used per transfection: 0.5 g of a reporter plasmid, 0.1 g of an expression plasmid, 0.5 g of pRL-TK coreporter plasmid (Promega), and 8.9 g of empty pBluescript plasmid DNA as a carrier. At 32 h posttransfection, cells were rinsed once with phosphate-buffered saline and harvested by adding of 500 l of 1ϫ reporter lysis buffer (Promega) and scraping with a rubber policeman. Protein concentrations of the lysates were determined by using the Bio-Rad protein assay reagent (Bio-Rad, Hercules, Calif.). Lysates (6 g of protein) were analyzed with the Dual Luciferase assay system (Promega) on a Dynex luminometer (Chantilly, Va.). Luciferase activity in each assay was normalized for transfection efficiency by measuring pRL-TK coreporter activity. The means (Ϯ standard errors) of two to six independent experiments are presented. Statistical analysis was performed by using Student's t test. A P value of Ͻ0.05 was considered significant. . Membranes were stained with Ponceau S to determine the quality of transfer and the equivalence of protein loading. Immunoblotting was performed with rabbit polyclonal antisera specific to ch-IAP1 or with monoclonal antibodies specific for v-Rel and c-Rel (HY87) (15) . Proteins were detected using the Renaissance Western blot chemiluminescence reagent (Perkin-Elmer Life Sciences, Boston, Mass.).
EMSAs. Electrophoretic mobility shift assays (EMSAs) and the preparation of nuclear extracts from CEF cultures have been described previously (14, 28) . The top strand of the wild-type (WT) and mutant (Mut) oligodeoxynucleotides used as probes for EMSAs were as follows:
Underlined sequences indicate the location of the B sites, and lowercase letters represent mutated positions. The bottom strand of the probe was synthesized by annealing a 9-bp oligonucleotide complementary to the 3Ј end of the top strand and extending with Klenow in the presence of [ 32 P]dCTP (14) . Antibodies against v-Rel, NF-B1, and NF-B2 used in supershift analyses have been previously described (14, 21, 24) . The c-Rel-specific antiserum (2348-6) was kindly provided by M. Hannink.
Nucleotide sequence accession number. The sequence of the ch-IAP1 genomic clone was submitted to GenBank (accession number AF311289).
RESULTS
The transcription rate of ch-IAP1 is increased in v-Relexpressing cells. Previous results from this laboratory have
demonstrated that the steady-state level of ch-IAP1 RNA is significantly elevated in v-Rel-transformed cells (32) . Elevated ch-IAP1 RNA levels may result from an increased rate of their transcription and/or a decreased rate of degradation. To define whether the transcription rate of ch-IAP1 is increased in v-Relexpressing cells, nuclear run-on assays were performed (19) . Nuclei were isolated from DT40 cells, DT40 cells infected with the helper virus REV-A (DT40-REV-A), or DT40 cells infected with a retrovirus expressing v-Rel (DT40-TW) and used in nuclear run-on reactions containing [ 32 P]UTP to produce radiolabeled pools of RNA. This RNA was hybridized with membranes onto which the ch-IAP1 cDNA had been immobilized. This analysis demonstrated that the transcription rate of ch-IAP1 was elevated approximately 10-fold in DT40-TW cells relative to the rate in DT40 or DT40-REV-A cells (Fig. 1A) . The cDNA of c-jun was included as a positive control for these experiments. The transcription of c-jun was elevated in DT40-TW cells relative to control cells, consistent with earlier findings that c-jun is transcriptionally upregulated by v-Rel (7, 8, 21) . Hybridization of the labeled RNA to genomic DNA demonstrated that comparable incorporation of radioactivity occurred in the nuclear run-on reactions, while negligible hybridization occurred with the pBluescript SK(Ϫ) negative control. This experiment was performed two additional times with similar results. Nuclear run-on experiments also revealed a 10-fold increase in the rate of ch-IAP1 transcription following overexpression of v-Rel in DT95 cells, an avian B-cell line (data not shown).
Analysis of the ch-IAP1 RNA half-life was performed to determine if changes in RNA stability also contribute to the increased steady-state level of ch-IAP1 in v-Rel-expressing cells. Total RNA was isolated from DT40-REV-A and DT40-TW cultures at various times after treatment with actinomycin D (2.5 g/ml) and subjected to Northern blot analysis with a ch-IAP1-specific probe (Fig. 1B, top panel) . Northern blots were quantitated by phosphorimager analysis and normalized to the signal obtained after stripping and hybridization with an actin-specific probe (Fig. 1B, lower panel) . The ch-IAP1 RNA exhibited a half-life of approximately 1 to 2 h in DT40 cells expressing v-Rel, in comparison to 4 to 6 h in control REV-A-infected DT40 cultures, indicating that the turnover of ch-IAP1 RNA is also enhanced in v-Rel-transformed cells. Taken together, these experiments indicate that the elevated levels of ch-IAP1 RNA in v-Rel-expressing cells are due to an increase in the rate of transcription, rather than an increase in RNA stability.
Isolation and characterization of ch-IAP1 promoter sequences. To determine whether v-Rel directly contributes to the increased transcription of ch-IAP1, the promoter of the ch-IAP1 gene was isolated. A chicken genomic library was screened with a probe specific to the 5Ј end of the ch-IAP1 cDNA. Two identical phage clones were isolated after screening approximately 250,000 plaques. Southern blot analysis, restriction mapping, and sequencing of a 10-kb EcoRI fragment revealed the junction of the 5Ј untranslated region of the ch-IAP1 cDNA and at least 5 kb of upstream sequences encompassing the putative promoter region. This fragment also contains a significant, though incomplete, portion of the coding region of ch-IAP1. The sequence of approximately 2 kb of this genomic clone is shown in Fig. 2 .
Primer extension analysis was performed to define the transcription start site for the ch-IAP1 gene. For these experiments, poly(A) ϩ RNA was isolated from a v-Rel-transformed cell line (7.4.1) that expresses high levels of ch-IAP1 and a chicken T-cell line (MSB-1) that expresses very low amounts of ch-IAP1 mRNA. The differential expression of ch-IAP1 by these cell lines was demonstrated by Northern blot analysis (Fig. 3A) . A primer complementary to the 5Ј untranslated region of the ch-IAP1 cDNA was end labeled with [␥-32 P]ATP, hybridized to 1 g of poly(A) ϩ RNA, and extended with reverse transcriptase. The products were analyzed by electrophoresis on a sequencing gel with a DNA sequencing ladder that permitted the sizing of the extension products to 1-bp resolution (Fig. 3B) . A primer extension product was not detected when mRNA from MSB-1 cells was analyzed (lane 1), consistent with the low levels of ch-IAP1 detected by Northern blot analysis. However, reactions containing mRNA isolated from v-Rel-transformed cells produced multiple extension products (lane 2). The most abundant primer extension product is 119 bases long and represents 35% of the total primer extension products. The corresponding nucleotide in the sequence of the ch-IAP1 genomic clone has been denoted as ϩ1 (Fig. 2) . Consistent with this, a putative TATA box resides 33 nucleotides upstream of this transcription start site. The sizes of other primer extension products corresponded to transcription start sites upstream of the cloned cDNA, while additional minor products corresponded to transcription start sites in sequences found at the beginning of exon 2 (Fig. 2) . The same pattern of primer extension products was observed in studies employing RNA isolated from DT95 cells expressing v-Rel (data not shown).
c-Rel stimulates the ch-IAP1 promoter more efficiently and through different B sites than v-Rel does. The exogenous expression of v-Rel and c-Rel correlates with the induction of ch-IAP1 RNA in fibroblasts and lymphoid cells (32) . Transient reporter assays were employed to evaluate the effect of v-Rel and c-Rel on ch-IAP1 promoter activity and to map the minimal ch-IAP1 promoter element that could confer inducibility to reporter genes by these Rel/NF-B proteins (Fig. 4) . Five promoter constructs derived from a 1.2-kb PstI fragment of the ch-IAP1 genomic clone were introduced in the pGL3-Basic luciferase reporter vector (Promega). CEF cultures were cotransfected with these constructs and the Rc/RSV expression plasmid or Rc/RSV encoding either v-Rel or c-Rel. Luciferase activity in extracts of the transfected cells was assayed after 32 h, a time when maximal activity was observed. The largest reporter construct (IAP1-luc), containing 1,001 bases upstream of the major transcription start site, exhibited approx- imately twofold-greater reporter activity when cotransfected with a vector encoding v-Rel than when a vector control was used (Fig. 4A ). This level of induction is comparable to that observed previously in studies demonstrating the direct activation of the avian ikba promoter by v-Rel (20) . Successive deletions of up to 822 nucleotides from the 5Ј end of this promoter sequence (IAP2-luc to IAP5-luc) did not significantly alter the v-Rel-inducible response of the promoter relative to that in Rc/RSV controls. These results indicate that sequences in the ch-IAP1 promoter within 179 bases upstream of the transcription start site are sufficient for the induction of ch-IAP1 expression by v-Rel. c-Rel is a more potent activator of transcription than v-Rel, and the ectopic expression of c-Rel increased reporter activity of IAP1-luc and IAP2-luc by approximately fourfold (Fig. 4A) . In contrast to v-Rel, sequential deletion of sequences between Ϫ367 and Ϫ179 (IAP3-luc to IAP5-luc) reduced the ability of c-Rel to induce reporter activity by half. ch-IAP1 promoter constructs lacking these sequences were activated by c-Rel and v-Rel to a comparable extent. These experiments establish that v-Rel and c-Rel differentially activate the ch-IAP1 promoter and that these proteins affect this activation through different sequences.
Inspection of the 1.2-kb PstI fragment of the ch-IAP1 genomic clone revealed at least four potential B sites upstream of the transcription start site (Fig. 2 and 4) . The locations of these B sites corresponded to sequences important for the Rel-inducible expression of the ch-IAP1 promoter (Fig.  4A) . One B site (B1) was found in the region of the ch-IAP1 promoter necessary for full activation by c-Rel, while B3 and B4 were found in the smallest reporter construct that is responsive to both v-Rel and c-Rel (IAP5-luc). To confirm that these sequences represent authentic B binding sites, EMSAs were performed (Fig. 5) . Oligonucleotides corresponding to these sequences were synthesized, labeled with [ 32 P]dCTP, and used in EMSA reactions with nuclear extracts prepared from CEF cultures infected with the helper virus CSV or with retroviruses expressing v-Rel or c-Rel (Fig. 5A ). All sites bound proteins from nuclear extracts of cells expressing v-Rel. Complexes from these cells most efficiently bound to B1, B3, and B4 and most weakly bound to B2. Although nuclear extracts from cells overexpressing c-Rel bound the B sites with a similar relative affinity, considerably lower levels of binding activity were observed. The differences in DNA binding activity observed in nuclear extracts from v-Rel-and c-Rel-overexpressing cells is more dramatic than that represented in Fig. 5 , since fivefold more protein was used in the EMSA analysis for c-Rel-overexpressing cells. The binding to these probes was specific for the B sites, since mutations in these sites abolished or greatly reduced binding in these assays. Additional studies revealed that the DNA binding complexes from v-Relexpressing cells were supershifted by the addition of antisera specific for v-Rel and that complexes from cells overexpressing c-Rel failed to bind DNA in the presence of antisera specific for c-Rel, thereby demonstrating the presence of v-Rel and c-Rel in these DNA binding complexes (Fig. 5B) . As the supershift analysis for all potential B sites provided similar results, only those for the B3 site are presented.
To define whether the use of these B sites by v-Rel or c-Rel can account for their ability to activate the ch-IAP1 promoter, site-directed mutagenesis was performed (Fig. 4B) . Each B site was mutated individually or in combination in the context of the smallest reporter vector that conferred maximum response to v-Rel and c-Rel (IAP2-luc). Reporter assays were then performed following coexpression of these constructs with vectors expressing c-Rel or v-Rel (Fig. 4C) . Mutations in B1 (IAP6-luc) or B2 (IAP7-luc) alone or in combination (IAP11-luc) did not significantly alter the ability of v-Rel to activate the reporter construct. However, mutations in B3 (IAP8-luc) or B4 (IAP9-luc) alone abolished the responsiveness of this promoter element to v-Rel. Similar results were obtained with a reporter construct that had mutations in both of these sites (IAP10-luc). These results indicate that v-Rel activates transcription from the ch-IAP1 promoter through B sites most proximal to the transcription start site (B3 and B4), while the most distal B sites (B1 and B2) are not required for ch-IAP1 activation by v-Rel.
The regulation of the ch-IAP1 promoter by c-Rel was more complex than that observed for v-Rel. Mutations in B1 (IAP6-luc) resulted in an approximately 40% reduction in the activation of the ch-IAP1 promoter by c-Rel. Mutations in B2 (IAP7-luc) did not significantly affect the ability of c-Rel to activate the ch-IAP1 promoter. The inability of c-Rel to activate the ch-IAP1 promoter from this site is consistent with the poor DNA binding activity of c-Rel complexes to B2 (Fig.  5A ). Mutations in both B1 and B2 (IAP11-luc) reduced the c-Rel-inducible expression of the reporter only slightly more than that observed for B1 alone. Mutation of B3 (IAP8-luc) or B4 (IAP9-luc) alone resulted in a 40 to 50% reduction in the ability of c-Rel to activate the ch-IAP1 promoter, relative to that of IAP2-luc. Mutation of both B3 and B4 (IAP10-luc) further reduced the ability of c-Rel to activate the reporter vector. However, when B1, B3, and B4 were mutated in combination (IAP12-luc), the promoter failed to exhibit any responsiveness to c-Rel. These results suggest that c-Rel activates the transcription of ch-IAP1 through B sites located in two distinct regions of the ch-IAP1 promoter.
Differences between the C termini of v-Rel and c-Rel mediate their differential effects on the ch-IAP1 promoter. v-Rel and c-Rel differ with regard to both their DNA binding specificities and their transactivation potentials, and these differences may account for their differential regulation of the ch-IAP1 promoter (9) . To determine the structural elements in c-Rel responsible for its ability to more efficiently activate ch-IAP1 promoter activity, a c-Rel protein C-terminally truncated to the size of v-Rel (c-Rel⌬T) and a chimeric protein containing the N terminus of v-Rel and the C-terminal transactivation sequences of c-Rel (ttc-Rel) were tested for their ability to activate the ch-IAP1 promoter ( Fig. 6A and B) (24) . While c-Rel was able to induce the activation of the IAP2-luc reporter construct fourfold, c-Rel⌬T activated the reporter at levels similar to v-Rel (twofold). In addition, c-Rel⌬T activated a reporter construct containing a mutated B1 site at reduced levels relative to c-Rel. These results indicate that the ability of c-Rel to utilize the B1 site to activate ch-IAP1 promoter activity is due to its potent C-terminal transactivation domain. Consistent with this, a v-Rel protein containing the C-terminal transactivation domain of c-Rel (ttc-Rel) was more efficient at activating IAP2-luc than v-Rel. This enhanced activation was mediated, at least in part, through the B1 site, since mutation of B1 (IAP6-luc) reduced the activation of the promoter by ttc-Rel. Moreover, unlike v-Rel, ttc-Rel was able to activate ch-IAP1 expression when the B3 and B4 sites were mutated (IAP10-luc), albeit at low levels.
Surprisingly, ttc-Rel was more efficient than c-Rel at activating IAP2-luc in reporter assays (eightfold versus fourfold). This difference was not due to differences in the expression of these proteins, as each of the Rel proteins was expressed at comparable levels from the Rc/RSV vectors (Fig. 6C) . In addition, since these proteins contain the same C-terminal sequences, differences in the transactivation potentials of these proteins are unlikely to account for their differential activation of ch-IAP1 reporter constructs. Therefore, EMSAs were performed to determine whether the abilities of these proteins to activate the ch-IAP1 promoter correlated with their binding affinities to the B1 site (Fig. 6D) . EMSAs performed using in vitro-translated v-Rel, c-Rel, c-Rel⌬T, and ttc-Rel demonstrated that proteins containing N-terminal v-Rel sequences (v-Rel and ttc-Rel) bound to B1 more efficiently than did those with N-terminal c-Rel sequences (c-Rel and c-Rel⌬T). The higher DNA binding affinity of v-Rel relative to c-Rel in these experiments indicates that the inability of v-Rel to activate transcription from B sites not in close proximity to the transcription start site is due to its lack of a potent transactivation domain. v-Rel, but not c-Rel, induces a sustained elevated expression of endogenous ch-IAP1 during transformation. We have previously observed that the levels of ch-IAP1 are higher in cells transformed by v-Rel than c-Rel (32) . However, the results described here demonstrate that c-Rel more efficiently activates transcription from the ch-IAP1 promoter than does v-Rel (Fig. 4) . To resolve this paradox, ch-IAP1 induction was monitored at various times following overexpression of v-Rel and c-Rel. CEF cultures were infected with retroviruses expressing v-Rel or c-Rel, or with the helper virus CSV. RNA was harvested at 2, 4, 8, and 14 days after infection and analyzed for the expression of ch-IAP1 by Northern blot analysis (Fig. 7A) . Two days after infection, the levels of ch-IAP1 RNA were elevated in cells overexpressing v-Rel, relative to control cells. The levels of ch-IAP1 in v-Rel-expressing cells gradually increased over time, attaining their highest levels when the cultures were morphologically transformed (day 14). Cells overexpressing c-Rel also contained elevated levels of ch-IAP1 RNA by 2 days after infection. However, in contrast to the expression pattern observed in cells expressing v-Rel, ch-IAP1 RNA levels in cells overexpressing c-Rel steadily decreased between 2 and 14 days. Similar changes in ch-IAP1 protein expression were observed in CEF cultures overexpressing vRel or c-Rel (Fig. 7B, top panel) . The changes in ch-IAP1 expression over time were not due to alterations in the levels of v-Rel or c-Rel (Fig. 7B, lower panel) . These results indicate that c-Rel transiently induces the expression of ch-IAP1, whereas v-Rel induces a sustained elevated expression of ch-IAP1 in transformed cells.
The differential ability of v-Rel and c-Rel to transform cells is due, in part, to their differential regulation by IB␣ (27) . IB␣ efficiently sequesters c-Rel in the cytoplasm of cells and directly inhibits its ability to bind DNA (4, 5, 27) . However, v-Rel has acquired mutations that make it refractory to IB␣ regulation (27) . To determine if the differential induction of ch-IAP1 expression by v-Rel and c-Rel correlates with the regulatory effects of IB␣, the subcellular localization and DNA binding activity of v-Rel and c-Rel were evaluated at various times after infection (Fig. 8) . Nuclear and cytoplasmic fractions were prepared from the CEF cultures described above. Two days after infection, cells infected with retroviruses expressing c-Rel contained nuclear and cytoplasmic c-Rel, although the cytoplasmic levels were much higher (Fig. 8A) . Between 2 and 14 days after infection, the nuclear levels of c-Rel decreased. This difference was not due to changes in the total amount of c-Rel in cells, since no significant differences in the levels of c-Rel in whole-cell and cytoplasmic extracts were observed ( Fig. 7B and 8A) . In contrast to c-Rel, cells expressing v-Rel contained comparable levels of nuclear and cytoplasmic v-Rel 2 days after infection. Moreover, the nuclear levels of v-Rel decreased more slowly and to a lesser extent than that observed for c-Rel. The more-efficient nuclear localization of v-Rel was not due to a lower induction of IB␣, because both v-Rel and c-Rel efficiently induced ⌱B␣ expression as early as 2 days after infection (data not shown). EMSA reactions were performed to determine whether changes in ch-IAP1 expression also correlated with changes in the DNA binding activity of v-Rel and c-Rel. B1 DNA binding activity in nuclear extracts isolated from CEF cultures infected with retroviruses expressing c-Rel rapidly decreased between 2 and 14 days after infection (Fig. 8B) . In contrast, the binding activity in nuclear extracts from v-Rel-expressing cells was much stronger and remained relatively steady between 2 and 14 days after infection. Similar results were observed for each of the four B sites found in the ch-IAP1 promoter (Fig.  8C ). These experiments demonstrate that shortly after its overexpression in cells, c-Rel is rapidly prevented from binding DNA and is efficiently retained in the cytoplasm. In contrast, v-Rel maintains its high nuclear levels and DNA binding activity over time.
In addition to the sustained level of DNA binding activity in nuclear extracts from cells expressing v-Rel, one additional DNA binding complex was observed bound to each of the four B sites at later stages of transformation (day 14). The appearance of this complex (Fig. 8B and C) coincided with a significant increase in the levels of ch-IAP1 (Fig. 7) . Supershift analysis was employed, using the B1 site as a probe to identify the proteins in this binding complex (Fig. 8D) . Whereas each of the binding complexes was efficiently supershifted with v-Relspecific antiserum, none of the complexes was affected by the addition of antiserum specific for c-Rel or NF-B2 (data not shown). However, the DNA binding complex that increased in abundance over time was supershifted with antiserum specific for NF-B1, indicating that it is composed of v-Rel/NF-B1 heterodimers. Similar experiments employing the B2 and B3 sites as probes confirmed that this additional complex was composed of v-Rel/NF-B1 heterodimers (data not shown).
DISCUSSION
Our previous studies have shown that the expression of ch-IAP1 is elevated in v-Rel-transformed cells (32) . In this report, nuclear run-on and RNA half-life analyses demonstrate that the elevated steady-state levels of ch-IAP1 RNA in cells expressing v-Rel is due to an increase in its rate of transcription (Fig. 1) . A genomic clone containing the ch-IAP1 promoter was isolated in order to investigate the mechanisms by which v-Rel elevates the rate of ch-IAP1 transcription (Fig. 2) . Primer extension experiments identified the major transcription start site of ch-IAP1 12 bp upstream of the cloned cDNA. Previous studies have cloned and partially characterized a genomic clone of c-IAP2, the human homolog of ch-IAP1 (12, 33) . Although the transcription start site of c-IAP2 has not been accurately defined, a genomic sequence upstream of the cloned cDNA that confers Rel/NF-B-inducible expression to reporter constructs has been identified (12) . The gross architecture of this genomic sequence and the ch-IAP1 promoter described here are similar, and both contain multiple functional Rel/NF-B sites. Results presented here indicate that ch-IAP1 is directly regulated by Rel/NF-B proteins and, moreover, the mechanisms that account for the difference in the ability of v-Rel and c-Rel to enhance the expression of ch-IAP1 have been defined.
The transient overexpression of v-Rel or c-Rel resulted in the activation of reporter vectors containing ch-IAP1 promoter sequences, although c-Rel did so approximately two times more efficiently than v-Rel (Fig. 4A) . Three B sites were found within 384 bp of the major transcription start site that conferred Rel-inducible activation of this promoter. The two B sites most proximal to the transcription start site (B3 and B4) were the only B sites required for activation of the ch-IAP1 promoter by v-Rel (Fig. 4C) . In contrast, the most distal B site (B1) and the two proximal B sites (B3 and B4) were all required for the full activation of the ch-IAP1 promoter by c-Rel. The additional activation of ch-IAP1 expression by c-Rel relative to v-Rel was largely due to the ability of c-Rel to activate transcription from B1 (Fig. 4C) . Muta- tions in this sequence diminished the activation of the ch-IAP1 promoter by c-Rel to levels similar to those observed for v-Rel. Interestingly, the binding activity of nuclear extracts from cells expressing v-Rel or c-Rel to B1 was comparable to that of B3 and B4 (Fig. 5) . Therefore, the ability of c-Rel to utilize and activate ch-IAP1 expression from this distal site was due to the presence of its potent C-terminal transactivation domain, rather than a preferential binding affinity. v-Rel lacks this transactivation domain and, presumably, can only execute its weak transactivation potential from B sites in close proximity to the transcription start site. Consistent with this interpretation, a c-Rel mutant that had this transactivation domain removed to the same extent as v-Rel activated reporter constructs to a similar extent as v-Rel (Fig. 6B) . Furthermore, a v-Rel mutant containing the C-terminal transactivation domain of c-Rel was able to activate reporter constructs from the distal B1 site. This is the first demonstration that c-Rel activates a promoter through a B site distinct from that used by v-Rel.
While the results described in this report demonstrate that c-Rel is a more potent activator of the ch-IAP1 promoter than v-Rel, our previous studies demonstrated higher levels of ch-IAP1 RNA in cells expressing v-Rel than in cells overexpressing c-Rel (32) . Kinetic analysis of ch-IAP1 expression demonstrated that ch-IAP1 levels were efficiently elevated in cells infected with viruses expressing v-Rel or c-Rel shortly after infection (Fig. 7A) . However, ch-IAP1 levels rapidly decrease over a 14-day period in cells overexpressing c-Rel. This decrease in ch-IAP1 expression was correlated with a decrease in c-Rel DNA binding activity and the relocalization of c-Rel to the cytoplasm (Fig. 7B and 8 ). These results, therefore, suggest that the efficient regulation of c-Rel by IB␣ results in its failure to induce sustained elevated levels of ch-IAP1.
In contrast, the levels of ch-IAP1 gradually increase in cells while they undergo transformation mediated by v-Rel (Fig.  7A) . The increase in ch-IAP1 expression during transformation is consistent with a secondary activation of the ch-IAP1 promoter by additional factors. Early after infection of cells with retroviruses expressing v-Rel, v-Rel homodimers are the predominant nuclear Rel/NF-B complex (14) . Approximately 1 week after infection, v-Rel heterodimers with endogenous Rel/NF-B proteins are found in the nuclei of cells (14) . We observed in this study that the appearance of v-Rel/NF-B1 heterodimers in B DNA binding complexes coincided with the increased expression of ch-IAP1 ( Fig. 7 and 8 (13, 21) . Previous studies analyzing the transcriptional regulation of v-Rel target genes have provided insight into the importance of the structural differences between v-Rel and c-Rel for transformation. Studies of the regulation of ikba demonstrated that the potent C-terminal transactivation domain of c-Rel was responsible for higher levels of ikba in cells overexpressing c-Rel relative to v-Rel, and this likely contributes to the low transformation potential of c-Rel (28) . In addition, the characterization of the transcriptional activation of c-jun by v-Rel revealed the importance of its DNA binding specificity. The altered DNA binding specificity of v-Rel relative to c-Rel allows for a higher affinity for the B site in the c-jun promoter and the more-efficient transcriptional activation of c-jun, a key player in transformation by v-Rel (7, 8, 21) . We have recently demonstrated that the elevated expression of ch-IAP1 by v-Rel is critical for transformation and that the differential regulation of ch-IAP1 by v-Rel and c-Rel contributes to their different transformation potentials (unpublished data). The results described in this study are the first to provide evidence that the more-efficient expression of a v-Rel target gene correlates with the ability of v-Rel to escape IB␣ regulation. The inability of IB␣ to sequester v-Rel in the cytoplasm allows for the continued presence of v-Rel in the nuclei of cells and the eventual nuclear translocation of v-Rel complexes with higher transactivation potentials (14, 16) . Therefore, the ability of v-Rel to be maintained at high levels in the nuclei of cells compensates for its weak transcriptional activation potential by leading to the gradual and sustained upregulation of target genes responsible for transformation.
